Login
Toggle navigation
Videos
Categories
Trending
CAREL Industries Spa's Officer aims to analyze the company's sales strategies, processes, and methodologies.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Francesco Nalini, CAREL Group CEO.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
About Addnode Group | Johan Andersson, CEO, Addnode Group AB (publ)ANOD B:STO
00:10:00
Medicare Enrollment Simplified: Comprehensive Guidance and Plan Options with Lynn Hunter from RBF Capital Management & Retirement Solutions | Discover How to Navigate Medicare with Ease
00:10:00
Denarius Metals Nears High-Grade Gold Production in Colombia
00:00:00
Neovasc uses conference to announce positive interim clinical data from Neovasc Reducer use - Bill Little, COO, Neovasc Inc
00:00:00
Universal Biosensors (ASX:UBI) John Sharman, CEO, Universal Biosensors Inc
00:10:00
Helps company in a large number of startups|Garry Tan,Partner,Y Combinator
00:10:00
Exploring the World of Children's Content with Genius Brands International CEO Andy Hayward
00:10:00
Industry Warning Signals: Red Flags Emerge for Dupont, Elektroimportøren, Tesla, and Giant Salmon | Gigante Salmon, CFO, Rune Johansen .
00:10:00
This video explores the key topic of recycling, addressing common questions and concerns surrounding the process.
00:10:00
CAMS CEO Anuj Kumar Highlights Company's Market Dominance and IPO Plans | Anuj Kumar, CEO, Computer Age Management Services Ltd.
00:10:00
Aalberts: Pioneering Material Innovation for Tomorrow's World
00:10:00
Aston Minerals (ASO) Emerges as a Key Player in the ASX Nickel Sector with Robust Resource Estimates at Edleston | Tolga Kumova, Chairman, Aston Minerals Ltd.